Literature DB >> 7592580

Quasi-native chaperonin-bound intermediates in facilitated protein folding.

G Tian1, I E Vainberg, W D Tap, S A Lewis, N J Cowan.   

Abstract

Chaperonins are known to facilitate protein folding, but their mechanism of action is not well understood. The fact that target proteins are released from and rebind to different chaperonin molecules ("cycling") during a folding reaction suggests that chaperonins function by unfolding aberrantly folded molecules, allowing them multiple opportunities to reach the native state in bulk solution. Here we show that the cycling of alpha-tubulin by cytosolic chaperonin (c-cpn) can be uncoupled from the action of cofactors required to complete the folding reaction. This results in the accumulation of folding intermediates which are chaperonin-bound, stable, and quasi-native in that they bind GTP nonexchangeably. We present evidence that these intermediates can be generated without the target protein leaving c-cpn. These data show that, in contrast to prevailing models, target proteins can maintain, and possibly acquire, significant native-like structure while chaperonin-bound.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592580     DOI: 10.1074/jbc.270.41.23910

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Eukaryotic chaperonin CCT stabilizes actin and tubulin folding intermediates in open quasi-native conformations.

Authors:  O Llorca; J Martín-Benito; M Ritco-Vonsovici; J Grantham; G M Hynes; K R Willison; J L Carrascosa; J M Valpuesta
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

2.  Disease-associated mutations in TUBA1A result in a spectrum of defects in the tubulin folding and heterodimer assembly pathway.

Authors:  Guoling Tian; Xavier H Jaglin; David A Keays; Fiona Francis; Jamel Chelly; Nicholas J Cowan
Journal:  Hum Mol Genet       Date:  2010-07-05       Impact factor: 6.150

3.  Cytosolic chaperonin protects folding intermediates of Gbeta from aggregation by recognizing hydrophobic beta-strands.

Authors:  Susumu Kubota; Hiroshi Kubota; Kazuhiro Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-22       Impact factor: 11.205

4.  A pachygyria-causing alpha-tubulin mutation results in inefficient cycling with CCT and a deficient interaction with TBCB.

Authors:  Guoling Tian; Xiang-Peng Kong; Xavier H Jaglin; Jamel Chelly; David Keays; Nicholas J Cowan
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

5.  The nucleotide-binding proteins Nubp1 and Nubp2 are negative regulators of ciliogenesis.

Authors:  Elena Kypri; Andri Christodoulou; Giannis Maimaris; Mette Lethan; Maria Markaki; Costas Lysandrou; Carsten W Lederer; Nektarios Tavernarakis; Stefan Geimer; Lotte B Pedersen; Niovi Santama
Journal:  Cell Mol Life Sci       Date:  2013-06-27       Impact factor: 9.261

6.  Infantile neurodegenerative disorder associated with mutations in TBCD, an essential gene in the tubulin heterodimer assembly pathway.

Authors:  Shimon Edvardson; Guoling Tian; Hayley Cullen; Hannah Vanyai; Linh Ngo; Saiuj Bhat; Adi Aran; Muhannad Daana; Naderah Da'amseh; Bassam Abu-Libdeh; Nicholas J Cowan; Julian Ik-Tsen Heng; Orly Elpeleg
Journal:  Hum Mol Genet       Date:  2016-11-01       Impact factor: 6.150

7.  Mutations in TUBB8 cause a multiplicity of phenotypes in human oocytes and early embryos.

Authors:  Ruizhi Feng; Zheng Yan; Bin Li; Min Yu; Qing Sang; Guoling Tian; Yao Xu; Biaobang Chen; Ronggui Qu; Zhaogui Sun; Xiaoxi Sun; Li Jin; Lin He; Yanping Kuang; Nicholas J Cowan; Lei Wang
Journal:  J Med Genet       Date:  2016-06-06       Impact factor: 6.318

8.  Cryptic out-of-frame translational initiation of TBCE rescues tubulin formation in compound heterozygous HRD.

Authors:  Guoling Tian; Melissa C Huang; Ruti Parvari; George A Diaz; Nicholas J Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

9.  Tubulin binding cofactor C (TBCC) suppresses tumor growth and enhances chemosensitivity in human breast cancer cells.

Authors:  Rouba Hage-Sleiman; Stéphanie Herveau; Eva-Laure Matera; Jean-Fabien Laurier; Charles Dumontet
Journal:  BMC Cancer       Date:  2010-04-12       Impact factor: 4.430

10.  ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.

Authors:  Anne Beghin; Stéphane Belin; Rouba Hage-Sleiman; Rouba Hage Sleiman; Stéphanie Brunet Manquat; Sophie Goddard; Eric Tabone; Lars P Jordheim; Isabelle Treilleux; Marie-France Poupon; Jean-Jacques Diaz; Charles Dumontet
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.